SCHEMBL13403294

SCHEMBL13403294

COCCNC(=O)c1cccc(/C=C/C(=O)c2c(O)cc(C)oc2=O)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.51
KMT2A Q03164 11/20 0.51
RAB9A P51151 6/20 0.51
MAPT P10636 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
POLB P06746 3/20 0.51
NPSR1 Q6W5P4 2/20 0.51
PLIN1 O60240 1/20 0.51
ALOX12 P18054 1/20 0.51
PLIN5 Q00G26 1/20 0.51
ABHD5 Q8WTS1 1/20 0.51
PPARG P37231 2/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 4/20 0.47
PKM P14618 3/20 0.47
USP2 O75604 3/20 0.47
RECQL P46063 2/20 0.47
GAA P10253 1/20 0.47
HTT P42858 1/20 0.47
NR3C1 P04150 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2277602 0.83 LMNA (0.40) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL2277607 0.83 LMNA (0.40) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL13403305 0.82 KDM4E (0.50) MEN1KMT2ARAB9AMAPTPOLB
SCHEMBL3524845 0.80 RAB9A (0.61) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL3524847 0.80 RAB9A (0.61) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL12374701 0.77 ALDH1A1 (0.40) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL12374855 0.75 MEN1 (0.48) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL13818097 0.73 PADI4 (0.40) MEN1KMT2AMAPTSMN1; SMN2POLB
SCHEMBL4520101 0.72 PADI4 (0.40) RAB9AMAPTNPSR1KDM4ENPC1
SCHEMBL4520097 0.72 PADI4 (0.40) RAB9AMAPTNPSR1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265228-A1 Cinnamoyl compound and use of the same NPC1, CES2, CYP51A1 MEN1 876/4885KMT2A 3443/4885RAB9A 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.